Medical Grade Chitosan Market Size, Share, Growth, and Industry Analysis By Type (Animal Origin Chitosan, Plant Based Chitosan), By Application (Wound Care, Healthcare Products, Antibacterial Products, Others), Regional Insights and Forecast From 2025 To 2033

Last Updated: 14 July 2025
SKU ID: 21051304

Trending Insights

Report Icon 1

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Report Icon 2

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

Report Icon 3

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels

MEDICAL GRADE CHITOSAN MARKET OVERVIEW

The global medical grade chitosan market size was USD 0.04 billion in 2024 and market is projected to touch USD 0.08 billion by 2033, compound annual growth rate (CAGR) of 7.8% during the forecast period.

Chitosan is a natural substance that is derived from the shells of crustaceans, such as crabs and shrimp. It is mainly used in food preservation, but also has some medical purposes such as preventing excessive weight accumulation and strengthening the capillary walls. It has been used as a biopolymer to produce various medical grade products such as film, hydrogels, coatings for catheters, wound dressings, and surgical devices. In the medical device industry, Chitosan has gained popularity over the last decade due to its ability to reduce biofilm formation and prevent infection. In recent years, Chitosan has been used extensively in surgical adhesive tapes because of its unique ability to adhere when wet.

KEY FINDINGS

  • Market Size and Growth: Valued at USD 0.04 billion in 2024, projected to touch 0.08 billion by 2033 at a CAGR of 7.8%.
  • Key Market Driver: Animal-origin chitosan accounted for 60% of total market usage due to high efficiency in biomedical applications.
  • Major Market Restraint: High purification costs affected nearly 40% of potential end-users, limiting broader industrial adoption.
  • Emerging Trends: Antibacterial applications represented 35% of overall market use, driven by increased demand in hospital-grade products.
  • Regional Leadership: North America captured 40% of global share due to rapid adoption in drug delivery and surgical care products.
  • Competitive Landscape: Top three players collectively held about 50% of the total market in 2024.
  • Market Segmentation: (By Type: Animal Origin – 60%, Plant-based – 40%; By Application: Antibacterial – 35%, Wound Care – 30%, Healthcare Products – 35%)
  • Recent Development: Plant-based medical-grade chitosan production rose by 25% in 2024 to support growing demand in clean-label products.

COVID-19 IMPACT

Market Witnessed Encouraging Impression During Pandemic

In the year 2019, the COVID-19 outbreak commenced in China and affected all the nations in the world gradually. Consequently, the pandemic impacted every business industry. The production rate decreased in several industries. However, the demand in the healthcare & pharmaceutical industry is increased. On the other hand, the demand for chitosan is rising. Because chitosan contains hydroxy and amino group which is helpful in COVID-19 diseases. Besides, during the lockdown period, the government imposed restrictions on other industries whereas the healthcare industry was permitted to work more & more to supply drugs for covid treatment.

LATEST TRENDS

Rising Awareness About Healthcare Among Consumers to Boost Market Growth

The latest trend in the market is that there has been an increased demand for better quality raw materials for the production of high-quality products. The driving factor behind this increasing demand due to the increased awareness about health and health care among consumers. Another factor is also the continued increase in the number of diseases and illnesses being diagnosed by doctors globally. The growth prospects are strong because these new trends show that consumption will continue to grow with time. With this increase in consumption, revenue will rise too as industry competition rises due to rapid growth in demand for new product development.

  • According to biomedical usage data, more than 1,500 scientific publications in 2023 explored chitosan's role in wound healing and drug delivery, showing growing research investment in medical-grade applications.
  • As per biomaterials usage surveys, over 30 countries approved chitosan-based wound care products and dressings for clinical use, with more than 250 product registrations globally by the end of 2023.
Global-Medical-Grade-Chitosan-Market-Share,-By-Type,-2033

ask for customizationRequest a Free sample to learn more about this report

MEDICAL GRADE CHITOSAN MARKET SEGMENTATION

By Type

On the basis of type, the market is separated into animal origin chitosan, plant based chitosan and others.

The animal origin chitosan is the largest segment of the market.

By Application

On the basis of application, the market is divided into wound care, healthcare products, antibacterial products.

The antibacterial products are the largest segment of the market.

DRIVING FACTORS

Benefits Of Cure Various Diseases to Enhance Market Growth

Medical Grade Chitosan is a substance that has been shown to be effective in treating complications such as plaque build-up, gum disease, and inflammation. The demand for chitosan is high because of its medical benefits.

Anti-Obesity Elements to Augment Market Growth

A number of pro-chitosan studies have been conducted over the past few years, showing that chitosan may be an effective therapy for obesity. This has led to an increased demand for chitosan in the medical grade area. In addition, with advances in technology and competition in this market shrinking rapidly, there will be more opportunities for growth in this area as well.

  • Based on wound management treatment standards, over 28 million chronic wound cases were recorded globally in 2023, supporting the demand for bioactive, hemostatic chitosan-based solutions.
  • According to pharmaceutical excipient regulations, chitosan has been recognized in more than 50 pharmacopeial entries, enabling its application in over 3,000 drug formulations for targeted release systems.

RESTRAINING FACTORS

Less Effective on Teeth to Constrain Market Growth

These growth projections lie upon companies investing heavily in research which leads to more awareness about chitosan as a health supplement. One potential restraint could be some reports suggesting that it may not work as well on teeth as it does on gums and that the benefits are short-lived when used over time.

  • According to marine resource regulatory assessments, over 75% of chitosan is derived from crustacean shells, creating allergen concerns and limiting acceptance in vegetarian or vegan medical formulations.
  • Based on FDA safety reports, chitosan with deacetylation levels below 85% fails to meet medical-grade classification, resulting in higher production costs and restricted supplier availability.

MEDICAL GRADE CHITOSAN MARKET REGIONAL INSIGHTS

Asia Pacific Leading the Market owing to Ease of Access

As regards of regional insights, Asia Pacific has emerged as a key revenue contributor due to easy accessibility of crustacean such as crabs, lobster, shrimps on the coastline in Asia continent. Further, the major consumer and producer countries are China, Thailand, and Japan. Which lead the market growth, demand & supply. Along with the increased adoption rates for medical grade chitosan supplements in this region due to its availability through online stores and traditional retail outlets boost the demand in the region. As a result, the leading regions are inducing the medical grade chitosan market growth.

KEY INDUSTRY PLAYERS

Competition among several industries 

The size of the medical grade chitosan market varies significantly in different regions as it is highly influenced by lifestyle habits that are not seen across regions. Pharmaceutical companies are producing more medical grade chitosan. Other than the demand in the pharmaceutical industry, the food, and water treatment industries need a chitosan supply. Therefore, the market growth rate is high and it is expected to grow in the future progressively. Prominent market players are investing in this industry and research. Leading brands such as Primex, and KitoZyme along with others are investing in and ruling the market with high revenue growth rate. Also, the major companies own the medical grade chitosan market shares.

  • Primex EHF: Primex processes over 1,000 tons of shrimp shells annually to produce high-purity medical-grade chitosan with deacetylation levels above 90%, serving biopharma and dental segments.
  • Kitozyme S.A.: Kitozyme produces non-animal, fungal-derived chitosan used in over 35 countries, with applications covering surgical mesh coatings and hemostatic pads.

List of Top Medical Grade Chitosan Companies

  • Primex
  • KitoZyme
  • BIO21
  • YSK
  • Vietnam Food
  • NovaMatrix
  • KIMICA
  • Ningbo Zhenhai Haixin Biological
  • Golden-Shell Pharmaceutical
  • Zhejiang Fengrun Biotech
  • Jiangsu Shuanglin
  • Jiangsu Aoxin Biotechnology
  • Qingdao Yunzhou Biochemistry

INDUSTRY DEVELOPMENT

The medical grade chitosan market has been developing due to its demand in medical, cosmetic, food, and water treatment relevancy. Along with this, chitosan is widely used in the medical industry to treat different health conditions, such as obesity, diabetes, gastric bypass surgery, and high cholesterol. The water treatment industry kept the largest share in the previous year as per the data report. The food industry holds enough amount of share in the chitosan market. In recent years, Chitosan is being used in food preservatives which enhance the shelf life of food.  Additionally, chitosan is Thus, the growth rate of the medical grade chitosan market is growing fast due to its rising demand in several industries.  

REPORT COVERAGE

This report is intended to give readers a general idea about the size of the medical grade chitosan market for future reference. Also, an overview of the medical grade chitosan market by product, region, and by application. Besides, this report discusses the latest trend in this field, growth forecast and share, driving factor and restraints, and identify various factors that are expected to have a positive impact on the growth of the chitosan market during the forecast period and give recommendations on how these factors can be leveraged to create future opportunities in the near term. As well as, the report explains, the COVID-19 impact on the industry and the geographical data analysis about the growing market, prominent competitors, their annual growth, manufacturing prices, and the demand rate in the food, pharmaceutical, and water treatment industry. The market is expanding in the last recent years also anticipated growing in the future.

Medical Grade Chitosan Market Report Scope & Segmentation

Attributes Details

Market Size Value In

US$ 0.04 Billion in 2024

Market Size Value By

US$ 0.08 Billion by 2033

Growth Rate

CAGR of 7.8% from 2025 to 2033

Forecast Period

2025-2033

Base Year

2024

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • Animal Origin Chitosan
  • Plant Based Chitosan

By Application

  • Wound Care
  • Healthcare Products
  • Antibacterial Products
  • Others

FAQs